Last reviewed: June 18, 2026 Last updated: June 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Price (Size) URL -.- Quick Product Notes :) Quick Product Notes :)
They looked at nearly a half million people taking a GLP-1 for their diabetes and compared them to a similar group of 1.6 million people taking other medications
It also has other effects, it is neuroprotective, increases bone formation, decreases stomach acid secretion, increases insulin release, stimulates fatty acid synthesis, and seems to promote the weight loss effect of GLP-1R activation
ROR, reporting odds ratio